HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: fj.07-8379revv1 21/13/3419    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ahmad, M. Articles by El-Agnaf, O. M. A. Search for Related Content PubMed PubMed Citation Articles by Ahmad, M. Articles by El-Agnaf, O. M. A.

-Synuclein and the progression of cancer

Mushfika Ahmad^*, Samir Attoub, Maneesh N. Singh, Francis L. Martin and Omar M. A. El-Agnaf^*,1

^* Department of Biochemistry and

Department of Pharmacology and Therapeutics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates; and

Biomedical Sciences Unit, Department of Biological Sciences, Lancaster University, Lancaster, UK

¹Correspondence: Department of Biochemistry, Faculty of Medicine and Health Sciences, United Arab Emirates, Al Ain, PO BOX 17666, United Arab Emirates. E-mail: o.elagnaf{at}uaeu.ac.ae

The synucleins are a small, soluble, highly conserved group of neuronal proteins that have been implicated in both neurodegenerative diseases and cancer. The synuclein family consists of -, ß-, and -synucleins (-syn). They are a natively unfolded group of proteins that share sequence homologies and structural properties (1, 2). So far, the biological functions of the synucleins are still unclear, but their involvement in neurodegenerative diseases and cancer may provide insights into the pathological processes that result from these two groups of debilitating diseases, and present the possibility to use them as potential targets for early diagnosis and treatment.

Recently, elevated levels of -syn proteins have been detected in various types of cancer, especially in advanced stages of the disease. Furthermore, studies to date indicate that overexpression of -syn compromises normal mitotic checkpoint controls, resulting in multinucleation as well as faster cell growth. -Syn has also been shown to promote invasion and metastasis in in vitro assays as well as in animal models. Overexpression of -syn also interferes with drug-induced apoptotic responses. These observations raise questions about the involvement of -syn in the process of tumorigenesis and metastasis, and efforts have already been made to use -syn as a marker for assessing breast cancer progression (3). This review will discuss the involvement of -syn in cancer progression, metastasis and its potential as a marker.—Ahmad, M., Attoub, S., Singh, M. N., Martin, F. L., El-Agnaf, O. M. A. -Synuclein and the progression of cancer.

Key Words: biomarker • apoptosis • invasion

This article has been cited by other articles:

				P. J. Oort, T. A. Knotts, M. Grino, N. Naour, J.-P. Bastard, K. Clement, N. Ninkina, V. L. Buchman, P. A. Permana, X. Luo, et al. {gamma}-Synuclein Is an Adipocyte-Neuron Gene Coordinately Expressed with Leptin and Increased in Human Obesity J. Nutr., May 1, 2008; 138(5): 841 - 848. [Abstract] [Full Text] [PDF]